Trial Profile
Cytokine Microdialysis For Real Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary) ; Relatlimab (Primary) ; Contrast media
- Indications Glioblastoma
- Focus Adverse reactions; Pharmacodynamics
- 20 Sep 2023 Status changed from active, no longer recruiting to completed.
- 01 Mar 2023 Status changed from recruiting to active, no longer recruiting.
- 21 Sep 2022 Status changed from active, no longer recruiting to recruiting.